Our strategy Our current strategic period started in 2021, setting out our vision and goals to achieve testing for healthy and safe lives.
ACT-Accelerator We co-convene the diagnostics pillar of this global collaboration to ensure access to COVID-19 tests for everyone, everywhere.
G20 in India We are highlighting the importance of diagnostics in ensuring that the G20 health priorities are achieved.
100 Days Mission A plan for the world to be able to respond to and extinguish the global threat of the next Disease X within 100 days of WHO declaring a major outbreak or pandemic.
Diagnostics & IP Find out how intellectual property rights are protected in the diagnostics industry.
Press release FIND welcomes adoption of historic World Health Assembly Resolution on diagnostics as the organization enters its 20th anniversary year
DxConnect Tools and resources provided under the DxConnect umbrella contain information managed and collated – but not owned – by FIND, as a service to the diagnostics community.
Data for decisions Diagnostics provide critical information for healthcare professionals, decision-makers, and people living with diseases and health conditions.
The diagnostic journey From R&D to implementation, the diagnostic value chain can be thought of as a journey of interconnected steps, or a "virtuous cycle".
Diagnostics Commission The Lancet Commission on diagnostics was published in 2021, putting forward recommendations to accelerate and transform access to diagnostics globally.
FIND welcomes adoption of historic World Health Assembly Resolution on diagnostics as the organization enters its 20th anniversary year The WHA Resolution is an historic milestone on the path to health for all, enabling countries to prioritize the systems and resources needed to ensure everyone who needs a test can get one – wherever and whenever they seek care, in a hospital, at a clinic, or at home through self-tests. FIND 30 May 2023
FIND deepens ties with the Republic of Korea to promote R&D and improve access to testing in low- and middle-income countries FIND 06 Jun 2023
FIND and VIA Global Health partner to expand access to quality diagnostics in low- and middle-income countries FIND 17 May 2023
Key stakeholders convene ahead of the G20 second health working group to strengthen global collaboration in research and accelerate regional manufacturing for diagnostics Government of India, Unitaid, FIND 16 Apr 2023
Diagnostics and intellectual property The pharmaceutical and vaccine industries both make regular use of patents to protect their innovative products. The situation for diagnostics is less straightforward; in many cases, patents are less consequential for diagnostics than for other health products.
Diagnostics and vaccines The benefits of vaccines are well known. However, vaccines cannot be developed, tested, targeted, or used efficiently and effectively without diagnostics. This document explains how diagnostics are a critical enabler for vaccines.
